Approval of Epidiolex Validates What Many CBD Users Already Knew
MedicalJane
JUNE 29, 2018
Food and Drug Administration (FDA) had approved only three cannabinoid-based medicines. percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed. Clinical trials show that Epidiolex significantly reduces seizure frequency. The Next Move Is On The DEA.
Let's personalize your content